Markets

Despite the uncertainty on the political front and the macroeconomic unknowns, the biotech sector's fundamentals have remained solid.

Problems are exemplified by Brexit

Favours EMD to mitigate rising rates

Surveyed in recent weeks

Rising 'negative inflation' a systemic risk

FCA should look at index providers first

The 'strength' of London cannot be 'relocated' elsewhere

Announced plans to merge last October

Sterling fell 0.25% to $1.281

This week's edition of Investment Week is now available to read online.